Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid for Cardioprotection in Off-pump CABG
NCT04806425Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Oct 2020
- Primary completion
- Feb 2021
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Intralipid 10% in Myocardial ischemia (MI) (2 arms), sponsored by Ain Shams University. Primary endpoint: Intensive Care Unit stay at 7 days. Started Oct 2020; status: completed.
02
Drugs
Intralipid 10%
03
Conditions
Myocardial ischemia (MI)
Beyond the preview
Go deeper on NCT04806425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04806425.